EphA2-derived peptide vaccine with amphiphilic poly(gamma-glutamic acid) nanoparticles elicits an anti-tumor effect against mouse liver tumor

Cancer Immunology, Immunotherapy : CII
Shinjiro YamaguchiNorio Hayashi

Abstract

The prognosis of liver cancer remains poor, but recent advances in nanotechnology offer promising possibilities for cancer treatment. Novel adjuvant, amphiphilic nanoparticles (NPs) composed of L: -phenylalanine (Phe)-conjugated poly(gamma-glutamic acid) (gamma-PGA-Phe NPs) having excellent capacity for carrying peptides, were found to have the potential for use as a peptide vaccine against tumor models overexpressing artificial antigens, such as ovalbumin (OVA). However, the anti-tumor potential of gamma-PGA-Phe NPs vaccines using much less immunogenic tumor-associated antigen (TAA)-derived peptide needs to be clarified. In this study, we evaluated the effectiveness of immunization with EphA2, recently identified TAA, derived peptide-immobilized gamma-PGA-Phe NPs (Eph-NPs) against mouse liver tumor of MC38 cells (EphA2-positive colon cancer cells). Immunization of normal mice with Eph-NPs resulted in generation of EphA2-specific type-1 CD8+ T cells. Immunization with Eph-NPs tended to provide a degree of anti-MC38 liver tumor protection more than that observed for immunization with the mixture of EphA2-derived peptide and complete Freund's adjuvant (Eph + CFA). Neither Eph-NPs nor Eph + CFA vaccines inhibited tumor growth of B...Continue Reading

References

Jun 1, 1989·Acta Pathologica Japonica·A NaramotoH Shigematsu
Sep 30, 1999·International Journal of Cancer. Journal International Du Cancer·D J EastyD C Bennett
May 12, 2000·Immunological Reviews·D G Doherty, C O'Farrelly
Jul 19, 2000·Current Opinion in Immunology·V E Schijns
Oct 18, 2001·The Annals of Thoracic Surgery·T A D'AmicoD H Harpole
Mar 22, 2002·Nature Reviews. Immunology·J A BerzofskyI M Belyakov
Jul 13, 2004·Biomacromolecules·Martin Obst, Alexander Steinbüchel
Dec 4, 2004·Gastroenterology·Simone MocellinDonato Nitti
Apr 5, 2005·Toxicologic Pathology·George A Parker, Catherine A Picut
Aug 30, 2005·Journal of Controlled Release : Official Journal of the Controlled Release Society·Takami AkagiMitsuru Akashi
Nov 10, 2005·Chemical Record : an Official Publication of the Chemical Society of Japan ... [et Al.]·Moon-Hee SungMakoto Ashiuchi
Oct 10, 2006·Journal of Biomaterials Science. Polymer Edition·Takami AkagiMitsuru Akashi
Feb 22, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Tomofumi UtoMasanori Baba
May 17, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Teresa A GilewskiPhilip O Livingston
May 23, 2007·Proceedings of the National Academy of Sciences of the United States of America·Danila ValmoriMaha Ayyoub
Jun 5, 2007·Advanced Drug Delivery Reviews·António J Almeida, Eliana Souto
Dec 11, 2007·Biochemical and Biophysical Research Communications·Tomoaki YoshikawaShinsaku Nakagawa
Jan 10, 2008·International Journal of Pharmaceutics·Kapil KhatriSuresh P Vyas
Apr 29, 2008·Cancer Immunology, Immunotherapy : CII·Shinjiro YamaguchiNorio Hayashi
Aug 5, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Andrew BottomleyGiuseppe Giaccone
Sep 18, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Miguel-Angel PeralesJedd D Wolchok
Jan 6, 2009·Biochemical and Biophysical Research Communications·Tomofumi UtoMasanori Baba
Jun 18, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jennifer M BrannanFaye M Johnson

❮ Previous
Next ❯

Citations

Aug 20, 2010·Pharmaceutical Research·Yogita KrishnamachariAliasger K Salem
Sep 8, 2010·Pharmaceutical Research·Wei-Yun Sheng, Leaf Huang
Dec 23, 2014·Nanomedicine·Mariusz Skwarczynski, Istvan Toth
Sep 9, 2016·Immunotherapy·Lucia SignoriniMarco Bregni
Jan 1, 2012·Vaccines·Aleksandra BartnikShi-Yu Yang
May 10, 2011·Science Progress·Igor Pantic
Sep 25, 2012·Bioorganicheskaia khimiia·S A Zozulya, I P Udovichenko
Oct 16, 2013·Expert Review of Vaccines·Francesca UngaroLuigi Buonaguro
Dec 12, 2018·Journal of Cellular Biochemistry·Mostafa SarvizadehMohsen Taghizadeh
Jul 16, 2020·Cancers·Eline JanssenDaniele V F Tauriello

❮ Previous
Next ❯

Related Concepts

Related Feeds

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.